Overview of RESONATE-2 clinical trial of ibrutinib in CLL
John Gribben et al.
The importance of PI3-kinase delta in CLL and NHL
Overview of 3 studies on CLL therapy: data on ibrutinib and a ROR1 inhibitor
How can doctors discuss CLL treatment options with patients?
Overview of the CLLR3 trial of obinutuzumab